|
|||||
|
|
Once-Weekly Subcutaneous Delivery of Polymer-Linked Rotigotine (SER-214) Provides Continuous Plasma Levels in Parkinson's Disease Patients |
|
| Authors: | C Warren Olanow MD David G Standaert MD Karl Kieburtz MD Tacey X Viegas PhD Randall Moreadith MD |
| Institution: | 1. Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA;2. Department of Neurology, University of Alabama, Birmingham, Alabama, USA;3. Clintrex Research Corporation, Sarasota, Florida, USA
Department of Neurology, University of Rochester, Rochester, New York, USA;4. Serina Therapeutics, Inc., Huntsville, Alabama, USA |
| Abstract: | |
| Keywords: | continuous delivery Parkinson's disease polymer-rotigotine |